Nakul Kadam

Efficacy of feverfew as prophylactic treatment of migraine.

E. S. Johnson, Nakul Kadam, D M Hylands et al. · BMJ · 1985 · 270 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas et al. · The Lancet Diabetes & Endocrinology · 2023 · 40 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones et al. · The Lancet Child & Adolescent Health · 2024 · 38 citations · Full text

Life Sciences, Immunology, Pediatrics +15

Chromosomal Aberrations and Sister Chromatid Exchanges in Lymphocytes and Urine Mutagenicity of Migraine Patients: A Comparison of Chronic Feverfew Users and Matched Non-users

Diana Anderson, P.C. Jenkinson, R.S. Dewdney et al. · Human Toxicology · 1988 · 26 citations

Life Sciences, Genetics, Toxicology +15